Vertex Historical Cash Flow

VRTX Stock  USD 417.51  0.19  0.05%   
Analysis of Vertex Pharmaceuticals cash flow over time is an excellent tool to project Vertex Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 3.4 B or Begin Period Cash Flow of 11 B as it is a great indicator of Vertex Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Vertex Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vertex Pharmaceuticals is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.

About Vertex Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Vertex balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Vertex's non-liquid assets can be easily converted into cash.

Vertex Pharmaceuticals Cash Flow Chart

Vertex Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Vertex Pharmaceuticals Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Vertex Pharmaceuticals' Cash And Cash Equivalents Changes is fairly stable compared to the past year. Change To Operating Activities is likely to rise to about 863.4 M in 2024, despite the fact that Change In Cash is likely to grow to (132.7 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Vertex Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Vertex Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from Vertex Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Vertex Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.At this time, Vertex Pharmaceuticals' Cash And Cash Equivalents Changes is fairly stable compared to the past year. Change To Operating Activities is likely to rise to about 863.4 M in 2024, despite the fact that Change In Cash is likely to grow to (132.7 M).
 2021 2022 2023 2024 (projected)
Capital Expenditures235M204.7M258.4M271.3M
Depreciation125.6M148.3M181.3M190.4M

Vertex Pharmaceuticals cash flow statement Correlations

0.560.620.160.280.370.460.42-0.190.33-0.730.36-0.09-0.330.38-0.46-0.17-0.390.4-0.310.150.30.27
0.56-0.010.880.890.830.970.96-0.370.91-0.670.91-0.79-0.67-0.49-0.89-0.32-0.610.91-0.40.290.890.87
0.62-0.01-0.3-0.22-0.21-0.05-0.110.19-0.16-0.21-0.150.480.160.540.150.13-0.04-0.14-0.430.03-0.07-0.32
0.160.88-0.30.950.760.890.96-0.310.95-0.410.91-0.91-0.58-0.79-0.83-0.24-0.530.91-0.290.220.940.88
0.280.89-0.220.950.780.890.95-0.360.91-0.520.98-0.89-0.61-0.66-0.86-0.32-0.620.9-0.320.270.930.89
0.370.83-0.210.760.780.780.8-0.120.78-0.50.84-0.77-0.6-0.5-0.73-0.55-0.250.77-0.310.510.720.7
0.460.97-0.050.890.890.780.95-0.440.9-0.60.91-0.81-0.7-0.57-0.88-0.26-0.680.91-0.520.190.920.85
0.420.96-0.110.960.950.80.95-0.340.96-0.570.93-0.86-0.62-0.62-0.89-0.27-0.60.95-0.350.240.950.89
-0.19-0.370.19-0.31-0.36-0.12-0.44-0.34-0.30.41-0.370.310.450.080.48-0.280.84-0.32-0.040.65-0.32-0.46
0.330.91-0.160.950.910.780.90.96-0.3-0.440.89-0.91-0.43-0.72-0.83-0.29-0.50.98-0.340.220.970.83
-0.73-0.67-0.21-0.41-0.52-0.5-0.6-0.570.41-0.44-0.590.350.62-0.190.820.390.59-0.430.2-0.05-0.46-0.53
0.360.91-0.150.910.980.840.910.93-0.370.89-0.59-0.85-0.66-0.59-0.88-0.4-0.630.88-0.410.310.920.86
-0.09-0.790.48-0.91-0.89-0.77-0.81-0.860.31-0.910.35-0.850.450.790.80.440.44-0.90.22-0.2-0.86-0.83
-0.33-0.670.16-0.58-0.61-0.6-0.7-0.620.45-0.430.62-0.660.450.190.660.140.66-0.440.34-0.12-0.46-0.65
0.38-0.490.54-0.79-0.66-0.5-0.57-0.620.08-0.72-0.19-0.590.790.190.390.150.16-0.670.18-0.2-0.7-0.61
-0.46-0.890.15-0.83-0.86-0.73-0.88-0.890.48-0.830.82-0.880.80.660.390.40.67-0.80.27-0.11-0.84-0.85
-0.17-0.320.13-0.24-0.32-0.55-0.26-0.27-0.28-0.290.39-0.40.440.140.150.4-0.12-0.280.16-0.53-0.29-0.2
-0.39-0.61-0.04-0.53-0.62-0.25-0.68-0.60.84-0.50.59-0.630.440.660.160.67-0.12-0.530.310.39-0.58-0.61
0.40.91-0.140.910.90.770.910.95-0.320.98-0.430.88-0.9-0.44-0.67-0.8-0.28-0.53-0.370.240.940.82
-0.31-0.4-0.43-0.29-0.32-0.31-0.52-0.35-0.04-0.340.2-0.410.220.340.180.270.160.31-0.37-0.3-0.47-0.16
0.150.290.030.220.270.510.190.240.650.22-0.050.31-0.2-0.12-0.2-0.11-0.530.390.24-0.30.220.21
0.30.89-0.070.940.930.720.920.95-0.320.97-0.460.92-0.86-0.46-0.7-0.84-0.29-0.580.94-0.470.220.82
0.270.87-0.320.880.890.70.850.89-0.460.83-0.530.86-0.83-0.65-0.61-0.85-0.2-0.610.82-0.160.210.82
Click cells to compare fundamentals

Vertex Pharmaceuticals Account Relationship Matchups

Vertex Pharmaceuticals cash flow statement Accounts

201920202021202220232024 (projected)
Change In Cash462.4M2.9B811.2M3.7B(139.7M)(132.7M)
Free Cash Flow1.5B3.0B2.4B3.9B3.3B3.4B
Change In Working Capital(66.1M)(54.5M)(105.2M)340.8M(265.7M)(252.4M)
Begin Period Cash Flow2.7B3.1B6.0B6.8B10.5B11.0B
Other Cashflows From Financing Activities24.8M276.4M130.3M3.5M(224.3M)(213.1M)
Depreciation106.9M109.5M125.6M148.3M181.3M190.4M
Capital Expenditures75.5M259.8M235M204.7M258.4M271.3M
Total Cash From Operating Activities1.6B3.3B2.6B4.1B3.5B3.7B
Net Income1.2B2.7B2.3B3.3B3.6B3.8B
Total Cash From Financing Activities126.8M(505.3M)(1.5B)(67.7M)(562.2M)(534.1M)
End Period Cash Flow3.1B6.0B6.8B10.5B10.4B10.9B
Other Non Cash Items(176.2M)(220.0M)(5.8M)103.4M(42.6M)(40.5M)
Change To Liabilities188.1M598.6M354.1M1.2B1.3B1.4B
Change To Account Receivables(225.6M)(223.4M)(274.7M)(358.6M)(84.1M)(88.3M)
Stock Based Compensation360.5M429.5M441.4M491.3M581.2M610.3M
Other Cashflows From Investing Activities(1.2B)(19.3M)(77M)(343.7M)(309.3M)(293.9M)
Change To Inventory(64.0M)(132.0M)(92.8M)(136.4M)(322.9M)(306.8M)
Total Cashflows From Investing Activities(1.2B)99.4M(340.9M)(321.1M)(289.0M)(274.5M)
Sale Purchase Of Stock(192.0M)(739.4M)(1.6B)(172M)(427.6M)(406.2M)
Dividends Paid20.8M10.0M264.9M102M117.3M123.2M
Investments33.7M378.5M(28.9M)227.3M(2.1B)(2.0B)
Change Receivables(225.6M)(223.4M)(274.7M)(358.6M)(322.7M)(306.6M)
Net Borrowings(35.0M)(29.0M)(24.4M)(85.5M)(77.0M)(73.1M)
Cash And Cash Equivalents Changes460.8M2.8B824.6M3.7B4.3B4.5B
Cash Flows Other Operating5.2M(332.2M)(263.5M)(453.2M)(407.9M)(387.5M)
Change To Netincome381.9M521.4M452.7M445.6M512.4M437.4M
Change To Operating Activities246.3M249.7M230.4M715M822.3M863.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.89
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.